Capula Management’s Cidara Therapeutics CDTX Stock Holding History

Capula Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,000	Closed	-$1.33M	–	1098
2025 Q4	$1.33M	Buy	+6,000	New	+$970K	0.01%	260

Capula Management's CDTX Position: Q1 2026 in Review

Capula Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 6,000 shares — an estimated $1.33M sold.

Capula Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.33M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Capula Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Capula Management sold 6,000 Cidara Therapeutics shares in Q1 2026, an estimated $1.33M.
Capula Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Capula Management's Cidara Therapeutics position peaked at $1.33M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.